Two Sigma Investments’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Two Sigma Investments’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-6,200	Closed	-$348K	–	3371
2017 Q2	$348K	Buy	+6,200	New	+$248K	﹤0.01%	2561

Two Sigma Investments's PTLA Position: Q3 2020 in Review

Two Sigma Investments sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 12,300 shares — an estimated $221K sold.

Two Sigma Investments first reported a position in PTLA in Q4 2013 and held it in 17 quarters. The position peaked at $21.2M in Q2 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Two Sigma Investments reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Two Sigma Investments sold 12,300 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $221K.
Two Sigma Investments first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 17 quarters.
Two Sigma Investments's Portola Pharmaceuticals, Inc. position peaked at $21.2M in Q2 2017.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Two Sigma Investments's 13F filing for Q3 2020, filed 16 Nov 2020.